Pembrolizumab versus paclitaxel for previously treated patients with PD-L1-positive advanced gastric or gastroesophageal junction cancer (GC): Update from the phase III KEYNOTE-061 trial.

Date
2020
Author
Mandala, Mario
Fornaro, Lorenzo
Olesinski, Tomasz
Caglevic, Christian
Chung, Hyun Cheol
Muro, Kei
Van Cutsem, Eric
Elme, Anneli
Thuss-Patience, Peter C.
Chau, Ian
Ohtsu, Atsushi
Bhagia, Pooja
Wang, Anran
Shih, Chie-Schin
Shitara, Kohei
Fuchs, Charles S.
Ozguroglu, Mustafa
Bang, Yung-Jue
Di Bartolomeo, Maria
Ryu, Min-hee
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/5087
Collections